Lantern Pharma Inc.
NASDAQ: LTRN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Panna Sharma
- Employees
- 24
- Headquarters
- Dallas, United States
- IPO year
- 2020
- Market cap
- $50.4M
- Website
- https://www.lanternpharma.com
Loading LTRN…
Loading profile data…Frequently asked questions about LTRN
What does Lantern Pharma Inc. (LTRN) do?
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-...
Where does LTRN trade?
Lantern Pharma Inc. (LTRN) trades on the NASDAQ Capital Market.
What sector is LTRN in?
Lantern Pharma Inc. (LTRN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lantern Pharma Inc.?
Panna Sharma is the chief executive officer of Lantern Pharma Inc. (LTRN).
Where is Lantern Pharma Inc. headquartered?
Lantern Pharma Inc. is headquartered in United States.
Does LTRN pay a dividend?
Lantern Pharma Inc. (LTRN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LTRN go public?
Lantern Pharma Inc. (LTRN) completed its initial public offering in 2020.